EP2970447
PAN-ELR+ CXC flakkboðamótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.3.2014EP published:
16.5.2018EP application number:
14711899.6
EP translation filed:
4.6.2018Grant published:
15.6.2018EPO information:
European Patent Register
Max expiry date:
4.3.2034Expiry date:
4.3.2027Next due date:
31.3.2027
Title:
PAN-ELR+ CXC CHEMOKINE ANTIBODIES
Timeline
Today
5.3.2014EP application
16.5.2018EP Publication
4.6.2018Translation submitted
15.6.2018Registration published
4.3.2027Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
BEIDLER, Catherine BrautigamAddress:
IndianapolisIndiana, US
Name:
KIKLY, Kristine KayAddress:
IndianapolisIndiana, US
Name:
STRIFLER, Beth AnnAddress:
IndianapolisIndiana, US
Name:
WITCHER, Derrick RyanAddress:
IndianapolisIndiana, US
Name:
BOYLES, Jeffrey StreetmanAddress:
IndianapolisIndiana, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361792800 PDate:
15.3.2013Country:
US
Classification
Categories:
C07K 16/18, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 14.2.2019
Expires: 4.3.2020
Payer: Örn Þór, slf.
Number: 7
Paid: 14.2.2020
Expires: 4.3.2021
Payer: Örn Þór slf.
Number: 8
Paid: 17.2.2021
Expires: 4.3.2022
Payer: Patice ehf.
Number: 9
Paid: 17.2.2022
Expires: 4.3.2023
Payer: Patice ehf.
Number: 10
Paid: 22.2.2023
Expires: 4.3.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 29.2.2024
Expires: 4.3.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 21.2.2025
Expires: 4.3.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.3.2026
Expires: 4.3.2027
Payer: Árnason Faktor ehf.